During the active phase of the experiment (conducted for 2 months), patients from group A received tamsulosin 0.4 mg/day once and solifenacin at a double dose of 20 mg/day once, patients from group B received tamsulosin 0.4 mg/day and solifenacin in a standard dose of 10 mg/day once, patients from group C received a placebo.
The text above was approved for publishing by the original author.
Allez simplement dans votre boîte de réception, cliquez sur le lien de confirmation que nous vous avons envoyé, et vous obtiendrez alors texte corrigé en retour. Si vous souhaitez corriger plusieurs emails
Ou